SCHEMBL21784645

SCHEMBL21784645

Oc1cc(O)c(-c2c(F)cccc2Cl)cc1-c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
TTR P02766 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP3A4 P08684 1/20 0.39
HSPD1 P10809 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
MAOB P27338 1/20 0.39
MAPK1 P28482 1/20 0.39
BRCA1 P38398 1/20 0.39
RECQL P46063 1/20 0.39
MMP14 P50281 1/20 0.39
DAPK1 P53355 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21784518 0.85 NMUR2 (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL20926551 0.82 ALDH1A1 (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL31067193 0.82 PBRM1 (0.44) MEN1KMT2AMAPTMAPK1TDP1
SCHEMBL9107868 0.82 ACMSD (0.47) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL21115448 0.81 KDM4E (0.41) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL22760434 0.79 ALDH1A1 (0.46) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL20754189 0.77 TSHR (0.42) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL24390321 0.76 TSHR (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL20926553 0.75 KMT2A (0.46) MEN1KMT2AMAPTHPGDALOX15
SCHEMBL18338750 0.75 ACMSD (0.48) MEN1KMT2AKDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO.,LTD. (JP) 2022-04-07 US disclosed
WO-2020044270-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2020-03-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220109115-A1 POLYCYCLIC COMPOUND, AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND ODC1, OTC, PKD1 MEN1 333/4885KMT2A 1453/4885ALDH1A1 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.